These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17133340)
21. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector. Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221 [TBL] [Abstract][Full Text] [Related]
22. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109 [TBL] [Abstract][Full Text] [Related]
23. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Schiedner G; Morral N; Parks RJ; Wu Y; Koopmans SC; Langston C; Graham FL; Beaudet AL; Kochanek S Nat Genet; 1998 Feb; 18(2):180-3. PubMed ID: 9462752 [TBL] [Abstract][Full Text] [Related]
25. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter. Shi CX; Graham FL; Hitt MM J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604 [TBL] [Abstract][Full Text] [Related]
26. Sustained expression after nonviral ocular gene transfer using mammalian promoters. Kachi S; Esumi N; Zack DJ; Campochiaro PA Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860 [TBL] [Abstract][Full Text] [Related]
27. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter. Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444 [TBL] [Abstract][Full Text] [Related]
29. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562 [TBL] [Abstract][Full Text] [Related]
30. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons. Huang D; Desbois A; Hou ST Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806 [TBL] [Abstract][Full Text] [Related]
31. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Ghersa P; Gobert RP; Sattonnet-Roche P; Richards CA; Merlo Pich E; Hooft van Huijsduijnen R Gene Ther; 1998 Sep; 5(9):1213-20. PubMed ID: 9930322 [TBL] [Abstract][Full Text] [Related]
32. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Varley AW; Coulthard MG; Meidell RS; Gerard RD; Munford RS Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5346-50. PubMed ID: 7539915 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-12 inhibits liver-specific drug-inducible systems in vivo. Reboredo M; Zabala M; Mauleon I; De Las Rivas J; Kreppel F; Kochanek S; Prieto J; Hernandez-Alcoceba R; Kramer MG Gene Ther; 2008 Feb; 15(4):277-88. PubMed ID: 18033307 [TBL] [Abstract][Full Text] [Related]
34. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Lipshutz GS; Flebbe-Rehwaldt L; Gaensler KM Mol Ther; 2000 Oct; 2(4):374-80. PubMed ID: 11020353 [TBL] [Abstract][Full Text] [Related]
35. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein. Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751 [TBL] [Abstract][Full Text] [Related]
36. In vitro effect of focused ultrasound or thermal stress on HSP70 expression and cell viability in three tumor cell lines. Hundt W; O'Connell-Rodwell CE; Bednarski MD; Steinbach S; Guccione S Acad Radiol; 2007 Jul; 14(7):859-70. PubMed ID: 17574136 [TBL] [Abstract][Full Text] [Related]
38. Sustained expression of human apo A-I following adenoviral gene transfer in mice. De Geest B; Van Linthout S; Collen D Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781 [TBL] [Abstract][Full Text] [Related]
39. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors. Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389 [TBL] [Abstract][Full Text] [Related]
40. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Sandig V; Löser P; Lieber A; Kay MA; Strauss M Gene Ther; 1996 Nov; 3(11):1002-9. PubMed ID: 9044740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]